These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22477663)
1. [Pollen allergy and immunotherapy]. Schmid-Grendelmeier P Ther Umsch; 2012 Apr; 69(4):239-48. PubMed ID: 22477663 [TBL] [Abstract][Full Text] [Related]
2. [Specific immunotherapy in hay fever: a practical overview]. Harder D; Schmid-Grendelmeier P Praxis (Bern 1994); 2009 Nov; 98(23):1353-60; quiz 1357, 1360. PubMed ID: 19918727 [TBL] [Abstract][Full Text] [Related]
3. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Czarnecka-Operacz M; Jenerowicz D; Silny W Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104 [TBL] [Abstract][Full Text] [Related]
4. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. Stringari G; Tripodi S; Caffarelli C; Dondi A; Asero R; Di Rienzo Businco A; Bianchi A; Candelotti P; Ricci G; Bellini F; Maiello N; Miraglia del Giudice M; Frediani T; Sodano S; Dello Iacono I; Macrì F; Peparini I; Povesi Dascola C; Patria MF; Varin E; Peroni D; Comberiati P; Chini L; Moschese V; Lucarelli S; Bernardini R; Pingitore G; Pelosi U; Tosca M; Cirisano A; Faggian D; Travaglini A; Plebani M; Matricardi PM; J Allergy Clin Immunol; 2014 Jul; 134(1):75-81. PubMed ID: 24794684 [TBL] [Abstract][Full Text] [Related]
5. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. Valenta R; Twaroch T; Swoboda I J Investig Allergol Clin Immunol; 2007; 17 Suppl 1():36-40. PubMed ID: 18050570 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
7. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
8. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation. Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924 [TBL] [Abstract][Full Text] [Related]
9. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882 [TBL] [Abstract][Full Text] [Related]
10. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy. Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322 [TBL] [Abstract][Full Text] [Related]
12. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G; Hurley C; Turcanu V; Lack G J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [TBL] [Abstract][Full Text] [Related]
13. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children. Del-Río Camacho G; Montes Arjona AM; Fernández-Cantalejo Padial J; Rodríguez Catalán J Allergol Immunopathol (Madr); 2018; 46(6):552-556. PubMed ID: 30017214 [TBL] [Abstract][Full Text] [Related]
14. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. Hylander T; Latif L; Petersson-Westin U; Cardell LO J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268 [TBL] [Abstract][Full Text] [Related]
15. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy? Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010 [TBL] [Abstract][Full Text] [Related]
16. [Allergic diseases of the upper and lower airways]. Grendelmeier SP Ther Umsch; 2008 Mar; 65(3):137-44. PubMed ID: 18551877 [TBL] [Abstract][Full Text] [Related]
17. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Sastre J; Landivar ME; Ruiz-García M; Andregnette-Rosigno MV; Mahillo I Allergy; 2012 May; 67(5):709-11. PubMed ID: 22379958 [TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy for Japanese cedar pollinosis. Okubo K; Gotoh M Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236 [TBL] [Abstract][Full Text] [Related]
19. Development of a sublingual allergy vaccine for grass pollinosis. Frati F; Scurati S; Puccinelli P; David M; Hilaire C; Capecce M; Marcucci F; Incorvaia C Drug Des Devel Ther; 2010 Jul; 4():99-105. PubMed ID: 20689696 [TBL] [Abstract][Full Text] [Related]
20. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]